Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    The Digital Health Challenge Facing Founders and Engineers in 2026

    October 7, 2026

    The Mental Health Crisis: What Psychiatrists and Policymakers Must Address Now

    October 6, 2026

    Navigating the Flood of New Clinical Trial Data

    October 5, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Health Magazine
    • Home
    • Environmental Health
    • Health Technology
    • Medical Research
    • Mental Health
    • Nutrition Science
    • Pharma
    • Public Health
    • Discover
      • Daily Health Tips
      • Financial Health & Stability
      • Holistic Health & Wellness
      • Mental Health
      • Nutrition & Dietary Trends
      • Professional & Personal Growth
    • Our Mission
    Health Magazine
    Home » News » Augered selects Hamamatsu Photonics’ CYTOQUBE® for personalized oncology research and treatment discovery
    Discover

    Augered selects Hamamatsu Photonics’ CYTOQUBE® for personalized oncology research and treatment discovery

    healthadminBy healthadminApril 15, 2026No Comments2 Mins Read
    Augered selects Hamamatsu Photonics’ CYTOQUBE® for personalized oncology research and treatment discovery
    Share
    Facebook Twitter Reddit Telegram Pinterest Email


    ORGAPRED, a French-based center of excellence specializing in patient-derived tumor organoid (PDTO) research, has selected Hamamatsu Photonics France’s high-throughput 3D imaging system CYTOQUBE to support personalized oncology drug screening and therapeutic discovery. This system enables rapid multicolor analysis of PDTO, enhancing ORGAPRED’s ability to assess treatment efficacy in these models.


    Hamamatsu x ORGAPRED team. From left: DESMARTIN Guillaume, EMICA Bruno, KOSSAYER Ghenwa, LECOUFLET Lucie, FLORENT Romane, D’ANGELO Jean Marc, Divoux Jordane, WEISWALD Louis-Bastien, POULAIN LAURENT, LE GOFF Jérémie. Image credit: © Hamamatsu Photonics

    Supporting personalized cancer treatment research and drug discovery

    ORGAPRED is an innovative center of excellence dedicated to the production of PDTO (also known as oncoid) to support personalized medicine and oncology research. Tumor-like material is generated using a patient’s tumor sample, cultured for several weeks, and distributed into 384 wells.

    Plate for drug testing. The CYTOQUBE system enables rapid 3D multicolor imaging to assess PDTO viability and cell death, providing a comprehensive assessment of treatment response.

    CYTOQUBE allows tumors to be analyzed in three dimensions across the entire plate, much faster than traditional imaging approaches. This allows drug responses to be compared more efficiently, supports personalized oncology research, and accelerates the identification of new effective treatment strategies. ”

    Dr. Romane Florent, ORGAPRED Research Engineer

    A collaboration developed over time

    The relationship between Hamamatsu Photonics France and ORGAPRED began in 2021 and has progressed through scientific exchanges, conferences and technology evaluations. In March 2025, an on-site system evaluation supported ORGAPRED’s funding application and subsequent public tender process, which was awarded in December 2025.

    Proven performance benefits

    During evaluation, the CYTOQUBE system demonstrated intuitive operation, simplified protocol creation, automated tumor segmentation, and clear data visualization. The system performs 3-color 3D analysis in less than 30 minutes, regardless of plate format (96, 384, or 1536 wells).

    By comparison, traditional confocal microscopy workflows can take more time due to multiple Z-stack acquisitions.

    sauce:

    Hamamatsu Photonics Europe



    Source link

    Visited 12 times, 1 visit(s) today
    Share. Facebook Twitter Pinterest LinkedIn Telegram Reddit Email
    Previous ArticleThis common gout drug may reduce risk of heart attack and stroke
    Next Article Proposal to install air monitors at industrial facilities in Louisiana fails
    healthadmin

    Related Posts

    Texas A&M researchers build AI tool for tuberculosis drug discovery

    July 30, 2026

    New ultrasound technology breaks blood-brain barrier to treat gliomas

    July 30, 2026

    Omalizumab wins multi-allergen oral immunotherapy in multi-food allergy trial

    July 30, 2026

    MAGFLO™ NGS beads: cost-effective nucleic acid purification

    July 30, 2026

    Qureight completes $20 million Series B funding

    July 30, 2026

    Cigarette smoke extract stimulates airway cells and increases nanoplastic damage

    July 30, 2026
    Add A Comment

    Comments are closed.

    Categories

    • Daily Health Tips
    • Discover
    • Environmental Health
    • Exercise & Fitness
    • Featured
    • Featured Videos
    • Financial Health & Stability
    • Fitness
    • Fitness Updates
    • Health
    • Health Technology
    • Healthy Aging
    • Healthy Living
    • Holistic Healing
    • Holistic Health & Wellness
    • Medical Research
    • Medical Research & Insights
    • Mental Health
    • Mental Wellness
    • Natural Remedies
    • New Workouts
    • Nutrition
    • Nutrition & Dietary Trends
    • Nutrition & Superfoods
    • Nutrition Science
    • Pharma
    • Preventive Healthcare
    • Professional & Personal Growth
    • Public Health
    • Public Health & Awareness
    • Selected
    • Sleep & Recovery
    • Top Programs
    • Weight Management
    • Workouts
    Popular Posts
    • 1773313737_bacteria_-_Sebastian_Kaulitzki_46826fb7971649bfaca04a9b4cef3309-620x480.jpgHow Sino Biological ProPure™ redefines ultra-low… March 12, 2026
    • pexels-david-bartus-442116The food industry needs to act now to cut greenhouse… January 2, 2022
    • 1773729862_TagImage-3347-458389964760995353448-620x480.jpgDespite safety concerns, parents underestimate the… March 17, 2026
    • 1774403998_image_28620e4b6b0047f7ab9154b41d739db1-620x480.jpgGait pattern helps distinguish between Lewy body… March 24, 2026
    • 1773209206_futuristic_techno_design_on_background_of_supercomputer_data_center_-_Image_-_Timofeev_Vladimir_M1_4.jpegMulti-agent AI systems outperform single models… March 11, 2026
    • Leukemia-620x480.jpgBiomimetic platform powers CAR T therapy for… March 9, 2026

    Demo
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    The Digital Health Challenge Facing Founders and Engineers in 2026

    By healthadminOctober 7, 2026

    Health tech founders, medical device engineers, and healthcare IT professionals face mounting pressure to scale telemedicine, wearable tech, and AI diagnostics amid rapid market expansion.

    The Mental Health Crisis: What Psychiatrists and Policymakers Must Address Now

    October 6, 2026

    Navigating the Flood of New Clinical Trial Data

    October 5, 2026

    The Urgent Gaps in Mental Health Care Access and Quality

    October 4, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    HealthxMagazine
    HealthxMagazine

    At HealthX Magazine, we are dedicated to empowering entrepreneurs, doctors, chiropractors, healthcare professionals, personal trainers, executives, thought leaders, and anyone striving for optimal health.

    Our Picks

    The Urgent Gaps in Mental Health Care Access and Quality

    October 4, 2026

    Integrating Medications and Non-Pharmacological Approaches: Addressing Gaps in Evidence-Based Psychiatric Care

    October 3, 2026

    Staying Ahead: Key Challenges in Tracking 2025-2026 Medical Breakthroughs

    October 2, 2026
    New Comments
      Facebook X (Twitter) Instagram Pinterest
      • Home
      • Privacy Policy
      • Our Mission
      © 2026 ThemeSphere. Designed by ThemeSphere.

      Type above and press Enter to search. Press Esc to cancel.